Trials / Recruiting
RecruitingNCT05489120
Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
Randomized Controlled Trial of a Low-Protein Diet (LPD) With Low-Protein (LP) Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD): Efficacy and Feasibility Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 244 (estimated)
- Sponsor
- Dr. Schär AG / SPA · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The KDOQI 2020 - Clinical practice guideline for nutrition in chronic kidney disease (CKD) -recommends protein restriction to reduce the risk of end-stage renal disease/death and improve quality of life, a low protein diet providing 0.55-0.60g dietary protein/ kg body weight/day is recommended. FLAVIS® is a product line of hypoprotein foods specially developed for the treatment of CKD.The use of low-protein foods may facilitate the achievement of nutritional goals in terms of protein intake and help patients to follow a low-protein diet.
Conditions
- Chronic Kidney Disease Stage 3B
- Chronic Kidney Disease stage4
- Chronic Kidney Disease Stage 5
- Chronic Kidney Disease Stage 3A
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Consumption of FLAVIS | Patients of the FLAVIS group will recevied FLAVIS products in addition to their diet follow-up. |
Timeline
- Start date
- 2022-11-06
- Primary completion
- 2026-03-01
- Completion
- 2026-03-01
- First posted
- 2022-08-05
- Last updated
- 2025-01-29
Locations
21 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05489120. Inclusion in this directory is not an endorsement.